These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 29276174)

  • 1. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience.
    Gurevich S; Oestreich B; Kelly RF; Mbai M; Bertog S; Yannopoulos D; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):621-625. PubMed ID: 29276174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
    Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes.
    Jose J; Sulimov DS; El-Mawardy M; Sato T; Allali A; Holy EW; Becker B; Landt M; Kebernik J; Schwarz B; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2017 Apr; 10(7):686-697. PubMed ID: 28385406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
    Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
    Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Anticoagulation After Tissue Aortic and Mitral Valve Replacement.
    Moonsamy P; Mohan N; Melnitchouk S
    Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):197-201. PubMed ID: 31870926
    [No Abstract]   [Full Text] [Related]  

  • 11. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation.
    Ruile P; Jander N; Blanke P; Schoechlin S; Reinöhl J; Gick M; Rothe J; Langer M; Leipsic J; Buettner HJ; Neumann FJ; Pache G
    Clin Res Cardiol; 2017 Feb; 106(2):85-95. PubMed ID: 27853942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report.
    Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Woldendorp K; Doyle MP; Black D; Ng M; Keech A; Grieve SM; Bannon PG
    J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1491-1499.e2. PubMed ID: 32217021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaflet thrombosis following transcatheter aortic valve implantation.
    Marwan M; Mekkhala N; Göller M; Röther J; Bittner D; Schuhbaeck A; Hell M; Muschiol G; Kolwelter J; Feyrer R; Schlundt C; Achenbach S; Arnold M
    J Cardiovasc Comput Tomogr; 2018; 12(1):8-13. PubMed ID: 29195844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of stroke after transcatheter prosthetic aortic valve implant with aortic bioprosthesis: subclinical thrombosis and possible therapeutic implications.
    Di Pasquale G; Coutsoumbas GV; Zagnoni S
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e46-e49. PubMed ID: 29045310
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
    Guedeney P; Mehran R; Collet JP; Claessen BE; Ten Berg J; Dangas GD
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007411. PubMed ID: 30630354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial.
    Giustino G; Tijssen J; Windecker S; Dangas G
    Cardiovasc Res; 2020 Mar; 116(3):e39-e41. PubMed ID: 32077477
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement.
    Del Trigo M; Muñoz-García AJ; Latib A; Auffret V; Wijeysundera HC; Nombela-Franco L; Gutierrez E; Cheema AN; Serra V; Amat-Santos IJ; Kefer J; Benitez LM; Leclercq F; Mangieri A; Le Breton H; Jiménez-Quevedo P; Garcia Del Blanco B; Dager A; Abdul-Jawad Altisent O; Puri R; Pibarot P; Rodés-Cabau J
    Heart; 2018 May; 104(10):814-820. PubMed ID: 29440192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
    Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.